Lloyd Marcea Bland
Insider CIK 1389208 · PSTX Director · AMLN SVP, Chief Administrative Offi
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 25,833 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 32,076 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 16,038 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 20,000 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 20,000 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 28,500 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 27,350 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 27,350 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | U Tender | 2025-01-08 | 2025-01-08 | 68,950 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2024-06-17 | 2024-06-18 | 27,350 | — | $0 | 27,350 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2024-06-17 | 2024-06-18 | 19,650 | — | $0 | 68,950 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 27,350 | — | $0 | 27,350 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2023-06-15 | 2023-06-16 | 19,650 | — | $0 | 49,300 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-16 | 28,500 | — | $0 | 28,500 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2022-06-16 | 2022-06-16 | 19,650 | — | $0 | 29,650 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2021-07-23 | 2021-07-26 | 25,833 | — | $0 | 25,833 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | P Buy | 2020-07-14 | 2020-07-15 | 10,000 | $16.00 | $160.0K | 10,000 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2020-07-09 | 2020-07-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 5,046 | $31.00 | $156.4K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 7,407 | $31.00 | $229.6K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 8,965 | $31.00 | $277.9K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 6,331 | $31.00 | $196.3K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 4,001 | $31.00 | $124.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 9,352 | $31.00 | $289.9K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 79,954 | $31.00 | $2.48M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 52,593 | $31.00 | $1.63M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 101,035 | $31.00 | $3.13M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 53,669 | $31.00 | $1.66M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 50,999 | $31.00 | $1.58M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 40,000 | $31.00 | $1.24M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 40,648 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 6,614 | $31.00 | $205.0K | 1,360 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 62,057 | $31.00 | $1.92M | 412 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 412 | $31.00 | $12.8K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 926 | $31.00 | $28.7K | 1,161 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 1,161 | $31.00 | $36.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 1,360 | $31.00 | $42.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 0 | $31.00 | $12 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award deriv | 2012-03-06 | 2012-03-07 | 101,035 | — | $0 | 101,035 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award deriv | 2012-03-06 | 2012-03-07 | 8,965 | — | $0 | 8,965 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-03-06 | 2012-03-07 | 1,529 | — | $0 | 7,974 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-03-06 | 2012-03-07 | 10,000 | — | $0 | 62,469 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | S Sale | 2012-03-01 | 2012-03-02 | 1,846 | $17.11 | $31.6K | 52,469 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | S Sale | 2012-02-23 | 2012-02-24 | 7,518 | $17.03 | $128.0K | 52,043 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-02-22 | 2012-02-24 | 20,000 | — | $0 | 59,561 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-02-08 | 2012-02-24 | 15,000 | — | $0 | 45,214 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | S Sale | 2012-02-08 | 2012-02-24 | 5,653 | $16.62 | $94.0K | 39,561 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-02-01 | 2012-02-10 | 473 | $15.53 | $7.4K | 2,087 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-01-10 | 2012-01-12 | 10,000 | — | $0 | 30,214 | SEC↗ |